Skip to main content

Quoin Pharmaceuticals Ltd.

QNRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001671502

In the last 90 days, Quoin Pharmaceuticals Ltd. insiders filed 4 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $6.29M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Quoin Pharmaceuticals Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
4 filings
4 insiders, $280.0K in total
Open-market sells
0 filings
Insiders trading
4
Net value
+$280.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Quoin Pharmaceuticals Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Quoin Pharmaceuticals Ltd.
NameTitleLast reported holdingLast filingFilings, past year
Carter Denise P.Chief Operating Officer37,709Sep 1, 20262
Myers MichaelChief Executive Officer37,713Sep 1, 20262
Lawlor Sally BridgetChief Financial Officer10,684Sep 1, 20263
Culverwell Anthony JamesDirector40,364Sep 1, 20263
Langer DennisDirector56,243Aug 28, 20263
Stonepine Capital Management, LLC10% Owner–Mar 31, 20261
Sember Michael TDirector–Feb 6, 20261
Cooper Joseph PatrickDirector–Feb 6, 20261
Leong Natalie Ee MunDirector–Feb 6, 20261
Dunn GordonChief Financial Officer151,077Dec 27, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 10, 2024 (view filing)Jun 73 daysLanger DennisDirectorSSale−297$0.73−$216.81−84.9%53 after
Sep 5, 2024 (view filing)Sep 3-42 daysMyers MichaelChief Executive OfficerPPurchase+37.9K$0.7657+$29.0K+404.9%47.3K after4 lots
Sep 5, 2024 (view filing)Sep 3-42 daysCarter Denise P.Chief Operating OfficerPPurchase+37.7K$0.7649+$28.9K+403.3%47.1K after4 lots
Sep 11, 2024 (view filing)Sep 9-102 daysDunn GordonChief Financial OfficerPPurchase+28.9K$0.8042+$23.2KNew position28.9K after5 lots
Dec 27, 2024 (view filing)5:15 PM ETDec 234 daysCulverwell Anthony JamesDirectorPPurchase+100.0K$0.45+$45.0K+31,545.7%100.3K after
Dec 27, 2024 (view filing)5:15 PM ETDec 234 daysCulverwell Anthony JamesDirectorPPurchaseADS+200.0K–––100.0K afterDerivative2 lots
Dec 27, 2024 (view filing)5:16 PM ETDec 234 daysDunn GordonChief Financial OfficerPPurchase+122.2K$0.45+$55.0K+423.6%151.1K after
Dec 27, 2024 (view filing)5:16 PM ETDec 234 daysDunn GordonChief Financial OfficerPPurchaseADS+244.4K–––122.2K afterDerivative2 lots
Dec 27, 2024 (view filing)5:16 PM ETDec 234 daysMyers MichaelChief Executive OfficerPPurchase+555.6K$0.45+$250.0K+1,175.7%602.8K after
Dec 27, 2024 (view filing)5:16 PM ETDec 234 daysMyers MichaelChief Executive OfficerPPurchaseADS+1.11M–––555.6K afterDerivative2 lots
Dec 27, 2024 (view filing)5:17 PM ETDec 234 daysCarter Denise P.Chief Operating OfficerPPurchase+555.6K$0.45+$250.0K+1,179.7%602.6K after
Dec 27, 2024 (view filing)5:17 PM ETDec 234 daysCarter Denise P.Chief Operating OfficerPPurchaseADS+1.11M–––555.6K afterDerivative2 lots
Oct 15, 2025 (view filing)Oct 141 dayLanger DennisDirectorPPurchaseADSs+15.2K$8.49+$128.6K+1,515,200.0%15.2K after
Oct 15, 2025 (view filing)Oct 141 dayLanger DennisDirectorPPurchaseADS+60.6K–––15.2K afterDerivative4 lots
Sep 1, 2026 (view filing)9:38 PM ETAug 311 dayCulverwell Anthony JamesDirectorPPurchaseADSs+6.15K$4.88+$30.0K+18.0%40.4K after
Sep 1, 2026 (view filing)9:38 PM ETAug 311 dayCulverwell Anthony JamesDirectorPPurchaseADS+3.07K–––3.07K afterDerivative
Sep 1, 2026 (view filing)9:39 PM ETAug 311 dayLawlor Sally BridgetChief Financial OfficerPPurchaseADSs+10.2K$4.88+$50.0K+2,328.2%10.7K after
Sep 1, 2026 (view filing)9:39 PM ETAug 311 dayLawlor Sally BridgetChief Financial OfficerPPurchaseADS+5.12K–––5.12K afterDerivative
Sep 1, 2026 (view filing)9:39 PM ETAug 311 dayMyers MichaelChief Executive OfficerPPurchaseADSs+20.5K$4.88+$100.0K+119.0%37.7K after
Sep 1, 2026 (view filing)9:39 PM ETAug 311 dayMyers MichaelChief Executive OfficerPPurchaseADS+10.2K–––10.2K afterDerivative
Sep 1, 2026 (view filing)9:40 PM ETAug 311 dayCarter Denise P.Chief Operating OfficerPPurchaseADSs+20.5K$4.88+$100.0K+119.0%37.7K after
Sep 1, 2026 (view filing)9:40 PM ETAug 311 dayCarter Denise P.Chief Operating OfficerPPurchaseADS+10.2K–––10.2K afterDerivative